Evidence map›Paper›PMID 32726578›Full record

ArticleMolecular cell2020

GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control.

Kelsey L Hickey, Kimberley Dickson, J Zachery Cogan, Joseph M Replogle, Michael Schoof, Karole N D'Orazio, Niladri K Sinha, Jeffrey A Hussmann, Marco Jost, Adam Frost and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 174 citations in OpenAlex.

  1. Review
  2. Review
  3. NNature · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ribosome-associated quality control and related mechanisms.Nature structural & molecular biology · 2026
    Review
  9. Quality control and signaling pathways at stalled ribosomes.Experimental & molecular medicine · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Kelsey L HickeyDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
Kimberley DicksonDepartment of Biology, Lawerence University, Appleton, WI 54911, USA.
J Zachery CoganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
Joseph M ReplogleDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
Michael SchoofDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.
Karole N D'OrazioDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.
Niladri K SinhaDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA.
Jeffrey A HussmannDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Marco JostDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
Adam FrostCalifornia Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Rachel GreenDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA; Howard Hughes Medical Institute, Carnegie Institution for Science, Baltimore, MD 21218, USA.
Jonathan S WeissmanDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94158, USA; Howard Hughes Medical Institute, Carnegie Institution for Science, Baltimore, MD 21218, USA. Electronic address: jonathan.weissman@ucsf.edu.
Kamena K KostovaDepartment of Embryology, Carnegie Institution for Science, Baltimore, MD 21218, USA. Electronic address: kostova@carnegiescience.edu.
University of California, San Francisco · USHoward Hughes Medical Institute · USJohns Hopkins University · USDepartment of Embryology · USLawrence University · USQB3 · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
PROJECT 3P50GM102706 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CATE, JAMIE H · 2012 to 2016
$9.5M
Molecular mechanisms of ribosome pausing and the cellular responseR37GM059425 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 2014 to 2023
$3.5M
How cells monitor the integrity of their translation apparatusDP5OD028147 · OD · STOWERS INSTITUTE FOR MEDICAL RESEARCH · PI KOSTOVA, KAMENA · 2019 to 2023
$2.0M
Human Gene Knockdowns that May Extend LifespanR01AG041826 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISSMAN, JONATHAN S. · 2012 to 2016
$1.6M
Deciphering the logic of glycolipid signaling at the host-microbiome interfaceK99GM130964 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOST, MARCO · 2019 to 2020
$200k
Howard Hughes Medical InstituteNIA NIH HHS R01 AG041826NIGMS NIH HHS K99 GM130964NIGMS NIH HHS P50 GM102706NIGMS NIH HHS R37 GM059425NIGMS NIH HHS T32 GM007445NIGMS NIH HHS T32 GM007618NIH HHS DP5 OD028147
6 · The paper itself

Abstract

Ribosome-associated quality control (RQC) pathways protect cells from toxicity caused by incomplete protein products resulting from translation of damaged or problematic mRNAs. Extensive work in yeast has identified highly conserved mechanisms that lead to degradation of faulty mRNA and partially synthesized polypeptides. Here we used CRISPR-Cas9-based screening to search for additional RQC strategies in mammals. We found that failed translation leads to specific inhibition of translation initiation on that message. This negative feedback loop is mediated by two translation inhibitors, GIGYF2 and 4EHP. Model substrates and growth-based assays established that inhibition of additional rounds of translation acts in concert with known RQC pathways to prevent buildup of toxic proteins. Inability to block translation of faulty mRNAs and subsequent accumulation of partially synthesized polypeptides could explain the neurodevelopmental and neuropsychiatric disorders observed in mice and humans with compromised GIGYF2 function.

Indexed as

Peptide Chain Initiation, TranslationalAnimalsCarrier ProteinsCRISPR-Cas SystemsEukaryotic Initiation Factor-4EHumansMiceProtein BiosynthesisProtein Processing, Post-TranslationalQuality ControlRibosomesRNA, MessengerUbiquitin-Protein LigasesCarrier ProteinsEIF4E2 protein, humanEukaryotic Initiation Factor-4EGIGYF2 protein, humanRNA, MessengerUbiquitin-Protein Ligases

Identifiers

PMID32726578
PMCPMC7891188
OpenAlexW3046000932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.